Two new Ebola vaccine candidates added to DR Congo clinical trial
The World Health Organization announced that two new candidate vaccines targeting the Bundibugyo species of Ebola will join clinical trials in the Democratic Republic of the Congo.
HEROIC BREAKING NEWS, written by our newsroom0 views
Two new vaccine candidates for Ebola will be added to an ongoing clinical trial in the Democratic Republic of the Congo, UN News, Türkiye Today, NHK, and Anadolu Ajansı reported. The UN World Health Organization announced the addition as the country continues to deal with an outbreak caused by the Bundibugyo species of the virus. [1][2][3][4][5]
According to UN News, the addition follows a recommendation by the World Health Organization's independent Technical Advisory Group on Candidate Vaccines Prioritization. UN News stated that this initiative marks the first time that vaccines specifically designed for the Bundibugyo species of the Ebola virus will be tested in a clinical trial. [1]
The Democratic Republic of the Congo is a country in Central Africa with a population of about 124 million people. Ebola virus disease typically causes high fever, severe headache, muscle pain, fatigue, and sore throat after an incubation period ranging from 2 to 21 days following exposure. [6][8]
In short
- Two new Ebola vaccine candidates will join clinical trials in the Democratic Republic of the Congo.
- The outbreak in the region is caused by the Bundibugyo species of the Ebola virus.
- The decision follows a recommendation by the World Health Organization's independent advisory group.
- This marks the first clinical trial specifically for vaccines designed against the Bundibugyo species.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]Two new Ebola vaccines to join DR Congo clinical trialUN News, 1h ago (the report this story comes from)
- [2]Two new candidate vaccines to join Ebola trial as treatment research advancesWorld Health Organization (WHO), 11h ago
- [3]Two more vaccine candidates to join Ebola trial in Congo, WHO saysTürkiye Today, 5h ago
- [4]Trials of two new Ebola vaccines to begin in DR CongoNHKニュース, 10h ago
- [5]WHO says 2 new candidate vaccines to join Ebola trial in DR CongoAnadolu Ajansı, 20h ago
Background
- [6]Democratic Republic of the Congo on Wikipedia
- [7]RVSV-ZEBOV vaccine on Wikipedia
- [8]Ebola on Grokipedia
- [9]Seres Therapeutics reports Phase 1b trial results for SER-155 treatment HEROIC BREAKING NEWS, 2d ago
- [10]Pro Democracy Activist Clovis Kakule Mutsuva Faces Military Trial in Congo HEROIC BREAKING NEWS, 6d ago
Our newsroom writes these reports with the help of software, from the 10 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from HEROIC BREAKING NEWS
Earlier reports of ours on the same people and subjects.
- Oxfam Mounts Ebola Response in DRC Following International Health EmergencyAid & Philanthropy, 13d ago
- Kenya traces contacts following country's first confirmed Ebola deathCivic Courage, 28d ago
- Ebola outbreak reaches eighth Congo province as Nigeria confirms first caseCivic Courage, 13d ago
- Kenya confirms first Ebola case and citizen death following flight from DRCTop Stories, 30d ago
- France commits seven million euros to DRC Ebola crisis responseComebacks & Recovery, 30d ago
More in Civic Courage
- Sydney teenager Isaac Khashadorian receives bravery award for rescuing family8h ago
- Syrian religious sister to receive Catholic courage award in London17h ago
- Five year old girl receives West Midlands Bravery Award after emergency call22h ago
- Rights groups urge Thailand not to deport two Uyghur men to China1d ago
- Teenager and mother reunite with Minnesota trooper who stopped out of control car1d ago
- Aid agencies provide hot meals to Oleshky evacuees in Kyiv2d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.
Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.